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Lou Vamina Gore and Dr Gregory R Naumiec
Department of Chemistry and Biochemistry, University of Central Arkansas, Conway, AR 72035

Introduction
Neglected tropical diseases (NTDs) affect the world’s
poorest population; mainly in Africa, Asia, and Latin
America. According to the WHO, more than one
billion people are affected by NTDs. The connection
between these areas is the lack of proper sanitation,
and the persistence of the diseases, trap the affected
countries in the poverty and disease cycle. African
sleeping sickness, a prevalent NTD, is mainly found
in Africa, and is a parasitic infection caused by two
parasites from the Trypanosoma brucei species.
Transmitted by the tsetse fly or congenitally, the
disease is manifested by fever, severe headaches,
irritability, extreme fatigue, swollen lymph nodes,
and aching muscles and joints ( stage 1). When it
reaches the central nervous system, it can cause
progressive confusion, personality changes, and
other neurological problems (stage 2). The high-cost
and limited number of the drugs contribute to the
increase of the cases resulting in a great impact on
global health.
The goal of our research is to develop inexpensive
and effective drugs using low-cost organic starting
materials that target the T. brucei parasite. Our target
compounds are Mannich bases containing an
aromatic moiety. Previous, but limited, studies have
shown that this class of compounds demonstrates
promising results against T. brucei. Our one step
synthesis involves the use of nitro-substituted
acetophenones, formaldehyde, and a variety of
amines to make Mannich bases under conventional
heating and microwave conditions. By changing the
nitro-acetophenones and the amines used in the
reaction, we hope to develop a robust drug library
we can use to screen against T. brucei.

Conclusion

Figure1: trypanosomes life cycle

Fig 2. The distribution of human African trypanosomiasis 2010–2014.

Method

NTDs represent a concern for the world’s
health and an important drugs resistance is
against several drugs is observed. In that
perspective, it is a mission to emerge with
new affordable types of drug available .To
that end, the synthesis Mannich bases are
crucial in African sleeping sickness drugs.
So far, the optimization condition of the
reaction have been set through several trials.
This represent a big step in the intent to
make efficient compounds
with cheap
starting materials and in great quantity in
the less amount of time.

Scheme 1: Synthesis the target mannich bases

Results

Scheme 2: Optimization reaction of our first Mannich base

Future work

Trial

Temperature
(°C)
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(W)
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1

85

15

100

19.38

2

95

15

100

31.39

3

85

25

100

55.81

4

95

25

100

18.60

5

85

40

100

42.63

▪

6

95

20

100

18.60

▪

The next step of this research is to develop a
library of Mannich bases drugs using
different amines and nitro-substituted
acetophenones compounds. The compound
will then be sent for testing against T. brucei.
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